PMC:6019327 / 688034-688300 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6019327","sourcedb":"PMC","sourceid":"6019327","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6019327","text":" Heart Rhythm 2014; 11: 202-209 (TTOP)733 2014 Randomized to phased RF ablation or AAD/cardioversion, multicenter 210 Persistent PVI + CFAEs 6 months Acute procedural success, ≥90% reduction in AF burden, off AAD 56% 26% \u003c0.001 12.3% NA Not FDA approved","divisions":[{"label":"td","span":{"begin":0,"end":41}},{"label":"td","span":{"begin":43,"end":47}},{"label":"td","span":{"begin":49,"end":115}},{"label":"td","span":{"begin":117,"end":120}},{"label":"td","span":{"begin":122,"end":132}},{"label":"td","span":{"begin":134,"end":145}},{"label":"td","span":{"begin":147,"end":155}},{"label":"td","span":{"begin":157,"end":219}},{"label":"td","span":{"begin":221,"end":224}},{"label":"td","span":{"begin":226,"end":229}},{"label":"td","span":{"begin":231,"end":237}},{"label":"td","span":{"begin":239,"end":244}},{"label":"td","span":{"begin":246,"end":248}}],"tracks":[]}